Margaret Dillon, Ph.D.

Margaret Dillon, our Senior Vice President of Regulatory Affairs and Quality Assurance, joined Cellerant in October 2010 with 19 years of regulatory experience in the biopharmaceutical industry. Previously, she worked at CV Therapeutics, Inc. for 9 years, serving most recently as Vice President, Regulatory Affairs. During this period, Margaret was involved with the development and US/EU marketing approvals for two new chemical entities for cardiovascular indications. Prior to this, Margaret was part of the regulatory groups at SyStemix, Inc., Connetics, Inc., and Schering-Plough Research Institute. Margaret holds a B.S. in Chemistry from SUNY Albany and a Ph.D. in Biochemical Pharmacology from SUNY Buffalo.


Copyright ©2006-2016 Cellerant Therapeutics, Inc.